HK1182383A1 - 激酶抑制劑的結晶形式 - Google Patents
激酶抑制劑的結晶形式Info
- Publication number
- HK1182383A1 HK1182383A1 HK13109690.9A HK13109690A HK1182383A1 HK 1182383 A1 HK1182383 A1 HK 1182383A1 HK 13109690 A HK13109690 A HK 13109690A HK 1182383 A1 HK1182383 A1 HK 1182383A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kinase inhibitors
- crystalline forms
- crystalline
- forms
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35317010P | 2010-06-09 | 2010-06-09 | |
| PCT/US2011/039603 WO2011156473A1 (en) | 2010-06-09 | 2011-06-08 | Crystalline forms of kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1182383A1 true HK1182383A1 (zh) | 2013-11-29 |
Family
ID=44454074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13109690.9A HK1182383A1 (zh) | 2010-06-09 | 2013-08-20 | 激酶抑制劑的結晶形式 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8633317B2 (zh) |
| EP (1) | EP2580221B1 (zh) |
| JP (1) | JP5727599B2 (zh) |
| CN (1) | CN103003283A (zh) |
| CA (1) | CA2802042A1 (zh) |
| ES (1) | ES2559212T3 (zh) |
| HK (1) | HK1182383A1 (zh) |
| MX (1) | MX2012014386A (zh) |
| WO (1) | WO2011156473A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015214182B2 (en) * | 2014-02-07 | 2020-04-30 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US20170197980A1 (en) * | 2014-06-25 | 2017-07-13 | Abbvie Inc. | N-(4-phenyl)-n'-(3-fluorophenyl)urea docusate |
| CN111848608A (zh) * | 2015-12-08 | 2020-10-30 | 浙江亚太药业股份有限公司 | 一种吡啶衍生物的v晶型及其制备方法、用途 |
| CA3017359A1 (en) | 2016-03-11 | 2017-09-14 | Scott M. Duncan | Crystalline salt forms |
| EP3606938A1 (en) | 2017-04-05 | 2020-02-12 | Stealth BioTherapeutics Corp | Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050020619A1 (en) * | 2003-07-24 | 2005-01-27 | Patrick Betschmann | Thienopyridine kinase inhibitors |
| US20050026944A1 (en) * | 2003-07-24 | 2005-02-03 | Patrick Betschmann | Thienopyridine and furopyridine kinase inhibitors |
| GB0402518D0 (en) * | 2004-02-05 | 2004-03-10 | Astrazeneca Ab | Therapeutic agents |
| US20070135387A1 (en) * | 2005-12-08 | 2007-06-14 | Michaelides Michael R | Inhibitors of protein kinases |
| RU2498988C2 (ru) * | 2008-03-05 | 2013-11-20 | Метилджин, Инк. | Ингибиторы активности протеинтирозинкиназы |
| MY179042A (en) | 2008-12-05 | 2020-10-26 | Abbvie Bahamas Ltd | Kinase inhibitors with improved cyp safety profile |
-
2011
- 2011-06-08 WO PCT/US2011/039603 patent/WO2011156473A1/en active Application Filing
- 2011-06-08 CN CN2011800375187A patent/CN103003283A/zh active Pending
- 2011-06-08 JP JP2013514335A patent/JP5727599B2/ja not_active Expired - Fee Related
- 2011-06-08 ES ES11726598.3T patent/ES2559212T3/es active Active
- 2011-06-08 EP EP11726598.3A patent/EP2580221B1/en not_active Not-in-force
- 2011-06-08 MX MX2012014386A patent/MX2012014386A/es active IP Right Grant
- 2011-06-08 CA CA2802042A patent/CA2802042A1/en not_active Abandoned
- 2011-06-08 US US13/156,070 patent/US8633317B2/en not_active Expired - Fee Related
-
2013
- 2013-08-20 HK HK13109690.9A patent/HK1182383A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2580221A1 (en) | 2013-04-17 |
| ES2559212T3 (es) | 2016-02-11 |
| US20120203002A1 (en) | 2012-08-09 |
| JP2013528222A (ja) | 2013-07-08 |
| WO2011156473A1 (en) | 2011-12-15 |
| EP2580221B1 (en) | 2015-10-21 |
| CN103003283A (zh) | 2013-03-27 |
| JP5727599B2 (ja) | 2015-06-03 |
| MX2012014386A (es) | 2013-05-01 |
| US8633317B2 (en) | 2014-01-21 |
| CA2802042A1 (en) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259135A1 (zh) | Vmat2的苯並喹啉酮抑制劑 | |
| ZA201208373B (en) | Compounds useful as inhibitors of atr kinase | |
| EP2552208A4 (en) | IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS | |
| HK1200828A1 (zh) | 激酶抑制劑 | |
| HK1192247A1 (zh) | 作為激酶抑制劑的雜環化合物 | |
| ZA201204136B (en) | Pteridinones as inhibitors of polo-like kinase | |
| HK1177205A1 (zh) | 惡唑的激酶抑制劑 | |
| EP2552214A4 (en) | PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS | |
| HUE048834T2 (hu) | Kináz inhibitorok | |
| EP2552211A4 (en) | INDAZOLYL-PYRIMIDINE AS KINASEHEMMER | |
| IL225605A0 (en) | Polo-like kinase inhibitors | |
| IL228103A0 (en) | Amino-quinolines as kinase inhibitors | |
| GB201009731D0 (en) | Kinase inhibitors | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| IL229028A0 (en) | Kinase inhibitors | |
| EP2685992A4 (en) | AMINO-QUINOLINES AS KINASE INHIBITORS | |
| HK1199873A1 (zh) | 激酶抑制劑 | |
| IL220187A0 (en) | Inhibitors of sphingosine kinase | |
| EP2758387A4 (en) | Pyridine compounds as kinase inhibitors | |
| HK1182383A1 (zh) | 激酶抑制劑的結晶形式 | |
| EP2531197A4 (en) | SOLID FORMS OF MACROCYCLIC CHINESE INHIBITORS | |
| ZA201300009B (en) | Oral formulation of kinase inhibitors | |
| HK1182384A1 (zh) | 激酶抑制劑的結晶形式 | |
| HK1179255A1 (zh) | 激酶抑制劑的晶體形式 | |
| GB201009730D0 (en) | Kinase inhibitor compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200607 |